Remove 2011 Remove Globalization Remove Leadership Remove Pharmaceuticals
article thumbnail

Pfizer’s Straight Talk on Culture

Michael Lee Stallard

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. You can see evidence of Pfizer’s commitment in Ian Read’s letter to stakeholders the year after he became CEO: In 2011, we thoroughly explored what our culture is and how it needs to evolve.

Ethics 150
article thumbnail

3 Ways to Confront Economic Adversity in 2011

Coaching Tip

Despite all the talk about the competitiveness of the global economy , the fact remains that for almost every rational human being on the planet, America remains the envy of the world and the land of opportunity. Please visit www.powerofadversity.net or www.weatherchem.com for more information.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Performance Measurement

Strategy Driven

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright (c) 2011. Copyright 2007-2011 by StrategyDriven, Inc.

ROIC 62
article thumbnail

Developing Global Leaders Is America's Competitive Advantage

Harvard Business Review

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

article thumbnail

China, South Africa Advance Sustainability Efforts

Harvard Business Review

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. His friend, Dr. Shiping Liu, founder and CEO of Global Business Intelligence Consulting Co., Daniela Saltzman is an MBA student at HBS, class of 2011. Stay tuned. Eccles is a professor of management practice at HBS.

article thumbnail

Recommended Resources – An Interview with Paul Leinwand and Cesare Mainardi, authors of The Essential Advantage

Strategy Driven

Those companies that ‘sweat’ their capabilities continuously improve them and sustainably capture the top-line growth in their industries and, ultimately, market leadership. He works with global Fortune 500 companies to help them achieve major business transformations. Copyright 2007-2011 by StrategyDriven, Inc.

article thumbnail

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business Review

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. Draetta of IACS has found many of the same issues arise in pharmaceutical research. In 2011, he commissioned a report that called for an “innovation policy” rather than an “industrial policy.”